Intra-Cellular Therapies ...

NASDAQ: ITCI · Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Statistics

Share Statistics

Intra-Cellular Therapies has 106.52M shares outstanding. The number of shares has increased by 0.9% in one year.

106.52M
0.9%
0.48%
91.2%
n/a
15,527
0.43%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -115.34 and the forward PE ratio is null. Intra-Cellular Therapies's PEG ratio is 2.28.

-115.34
n/a
12.65
4.2
7.5
-117.19
2.28
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Intra-Cellular Therapies.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.01.

6.36
6.23
0.01
-0.15
-0.23
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$791,688.37
$-86,832.56
860
0.5
2.17

Taxes

473K
-0.64%

Stock Price Statistics

The stock price has increased by 80.35% in the last 52 weeks. The beta is 0.46, so Intra-Cellular Therapies's price volatility has been higher than the market average.

0.46
80.35%
129.42
92.67
84.54
3,621,742

Income Statement

In the last 12 months, Intra-Cellular Therapies had revenue of 680.85M and earned -74.68M in profits. Earnings per share was -0.72.

680.85M
623.89M
-116.72M
-74.68M
-116.72M
-116.72M
-0.72
Full Income Statement

Balance Sheet

The company has 306.95M in cash and 16.98M in debt, giving a net cash position of 289.97M.

306.95M
16.98M
289.97M
-1.69B
1.37B
1.1B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73.18M and capital expenditures -322K, giving a free cash flow of -73.5M.

-73.18M
-322K
-73.5M
-0.71
Full Cash Flow Statement

Margins

Gross margin is 91.63%, with operating and profit margins of -17.14% and -10.97%.

91.63%
-17.14%
-10.9%
-10.97%
-17.14%
-17.14%
-10.8%

Dividends & Yields

ITCI does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ITCI is $132, which is 0.1% higher than the current price. The consensus rating is "Hold".

$132
0.1%
Hold
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

38.03
2